| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Transaction creates increased clinical and economic value for 11,500 specialty providers, including more than 7,000 physicians across 1,200 independent physician practices Transaction creates...
Progress achieved on company's ongoing business and portfolio review Completed review of growth businesses within the Medical Segment: investing in and further developing at-Home Solutions and...
Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2024 on February 1, prior to the opening of trading on the New York Stock Exchange. The company...
Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.5006 per share out of the Company's capital surplus. The dividend will be payable on...
Read more about Cardinal Health Board of Directors Approves Quarterly Dividend
SmartGown™ EDGE is the first pocketed surgical gown designed to help maintain instrument sterility and accessibility. DUBLIN, Ohio, Nov. 9, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH)...
Revenue increased 10% to $54.8 billion GAAP1 operating loss was $14 million and GAAP diluted EPS was $0.02, driven by a Medical segment goodwill impairment Non-GAAP operating earnings increased 35% to
Read more about The Harvard Drug Group, LLC Issues Voluntary Nationwide Recall of Certain Rugby® Laboratories Brand Eye Drops Supplied by Velocity Pharma, LLC Due to Potential Risk of Eye Infections
Read more about Cardinal Health, Inc. Issues Voluntary Nationwide Recall of Certain LEADER™ Brand Eye Drops Supplied by Velocity Pharma, LLC Due to Potential Risk of Eye Infections
Cardinal Health (NYSE: CAH) has been named among the 100 Best Corporate Citizens, a prestigious annual ranking by 3BL Media that assesses the environmental, social and governance (ESG)...
Read more about Cardinal Health Named to 100 Best Corporate Citizens of 2023
The next generation in enteral feeding, Kangaroo OMNI™ delivers nutrition and hydration from hospital to home. DUBLIN, Ohio, Sept. 28, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced...
Read more about Cardinal Health Launches Kangaroo OMNI™ Enteral Feeding Pump
Cardinal Health (NYSE: CAH) plans to release first-quarter financial results for its fiscal year 2024 on November 3, prior to the opening of trading on the New York Stock Exchange. The company...
Read more about Cardinal Health to Announce First-Quarter Results for Fiscal Year 2024 on November 3
Cardinal Health Foundation will invest $1.7M to help 14 children's hospitals nationwide prevent youth suicide. DUBLIN, Ohio, Sept. 13, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) in...
The NTrainer™ System 2.0 is the only FDA Class II biofeedback device designed to help newborns and infants born prematurely develop their non-nutritive sucking skills needed for independent oral...
Read more about Cardinal Health Launches Next Generation Medical Device to Improve Neonatal Feeding
Fourth quarter revenue increased 13% to $53.5 billion Fourth quarter GAAP1 operating earnings were $137 million and GAAP diluted loss per share was $0.25 Fourth quarter non-GAAP operating earnings...
Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.5006 per share out of the Company's capital surplus. The dividend will be payable on...
Read more about Cardinal Health Board of Directors Approves Quarterly Dividend
Cardinal Health (NYSE: CAH) plans to release fourth-quarter and year-end financial results for its fiscal year 2023 on August 15, prior to the opening of trading on the New York Stock Exchange....
New facility is the largest at-Home Solutions has built to date, set to accommodate continued business and home healthcare industry growth DUBLIN, Ohio, June 15, 2023 /PRNewswire/ -- Cardinal...
Read more about Cardinal Health to build at-Home Solutions distribution center in South Carolina
Narrowing fiscal year 2023 non-GAAP diluted EPS guidance to $5.65 to $5.80, from $5.60 to $5.80 (13% growth at the mid-point)1 Providing preliminary fiscal year 2024 non-GAAP diluted EPS guidance...
Read more about Cardinal Health Investor Day to Highlight Long-Term Value Creation
Cardinal Health's Outcomes™ business will combine with Transaction Data Systems to offer improved patient engagement and clinical pharmacy solutions, expanding connections between payers and...
Cardinal Health (NYSE: CAH) today launched modern payment solutions, powered by Square, to help independent pharmacies increase operational efficiency, stay current with customer payment...
Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved an increase to the Company's quarterly dividend, to $0.5006 per share, out of the Company's capital surplus. The...
Read more about Cardinal Health Board of Directors Approves Increase to Quarterly Dividend
Revenue increased 13% to $50.5 billion GAAP1 operating earnings were $572 million; GAAP diluted EPS was $1.34 Non-GAAP operating earnings increased 11% to $606 million; non-GAAP diluted EPS...
The new facilities represent Cardinal Health's ongoing commitment to servicing customers, warehousing modernization and growing the local economy DUBLIN, Ohio, April 17, 2023 /PRNewswire/ --...
Read more about Cardinal Health unveils two distribution centers in Central Ohio
Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2023 on May 4, prior to the opening of trading on the New York Stock Exchange. The company will...
Read more about Cardinal Health to Announce Third-Quarter Results for Fiscal Year 2023 on May 4